Targeted therapy uses microbubbles to transport medication directly to its destination.

Innovative platform trial revolutionizes ALS research by testing multiple treatments simultaneously, offering new hope ...

PathMaker Neurosystems Inc. (“PathMaker”), a clinical-stage neuromodulation company pioneering a breakthrough non-invasive treatment approach for amyotrophic lateral sclerosis (ALS), is pleased to ...

Flack had been diagnosed with the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS), in 2022. Warwick took to X ...

The US singer was known for songs including Killing Me Softly With His Song and The First Time Ever I Saw Your Face.

NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Voyager ...

Throughout history, stories have circulated about famous individuals who mocked God and later met tragic or untimely deaths.

Flack reached her breakthrough moment with "First Take" which she released in 1969 and included "The First Time Ever I Saw ...

Clene (NASDAQ: CLNN) has entered into an agreement with Germany-based APST Research GmbH to utilize its extensive neurofilament light chain (NfL) da ...

A new study has found that increasing the levels of "healthy fats" may improve survival in a motor neurone disease model.

Roberta Flack, the genre-blending R&B singer behind such hits as "Killing Me Softly With His Song," was selected to receive a ...

Singer Roberta Flack has died. Her team revealed her cause of death. Three years before she died, she shared her ALS ...